Last updated on April 2020

Efficacy And Safety Of Tofacitinib In Chinese Subjects With Active Psoriatic Arthritis


Brief description of study

This is a 6 month study investigating the effectiveness and safety of tofacitinib in treating signs and symptoms and improving physical function in Chinese patients with active psoriatic arthritis and had inadequate response to a conventional synthetic disease modifying anti-rheumatic drug. This is a China alone study.

Clinical Study Identifier: NCT03486457

Find a site near you

Start Over